Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice. 2002

Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, NJ 08854-8082, USA.

Mice null for the Pms2 mismatch repair (MMR) gene exhibit a predisposition to lymphoma, microsatellite repeat instability, and failure of spermatogenesis. To study the role of Pms2 in the maintenance of in vivo genomic integrity in somatic cells, we characterized Aprt mutations in T cells and fibroblasts of 129 x C3H Pms2-/-Aprt+/- mice. The spontaneous frequency of DAP-resistant T lymphocytes, as a consequence of APRT-deficiency, was increased threefold. Point mutation, which accounted for less than 20% of the DAP(r) mutant clones in Pms2+/+ mice, was predominant in the mutant T cell clones from Pms2-/- mice. These point mutations were predominantly TA to CG transitions. Fibroblasts of Pms2-/- mice exhibited only a modest increase in the frequency of clones with point mutations, such that mitotic recombination was still the primary cause of APRT deficiency. Thus, the mutator phenotype as a consequence of PMS2 deficiency is tissue-dependent, which may be related to the tissue-specific tumor proneness of Pms2-/- mice.

UI MeSH Term Description Entries
D007041 Hypoxanthine Phosphoribosyltransferase An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or MERCAPTOPURINE to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8. Guanine Phosphoribosyltransferase,HPRT,Hypoxanthine-Guanine Phosphoribosyltransferase,IMP Pyrophosphorylase,HGPRT,HPRTase,Hypoxanthine Guanine Phosphoribosyltransferase,Phosphoribosyltransferase, Guanine,Phosphoribosyltransferase, Hypoxanthine,Phosphoribosyltransferase, Hypoxanthine-Guanine,Pyrophosphorylase, IMP
D008297 Male Males
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D000070976 Mismatch Repair Endonuclease PMS2 A MutL protein and component of the DNA MISMATCH REPAIR system. Its ENDONUCLEASE activity introduces SINGLE-STRAND DNA BREAKS which create entry points for EXO1 exonuclease to remove the strand containing the mismatch. It may also function in DNA DAMAGE signaling. PMS-2 Protein,PMS1 Homolog 2, Mismatch Repair Protein,PMS2 Protein,Postmeiotic Segregation Increased-S. cerevisiae-2,PMS 2 Protein,Postmeiotic Segregation Increased S. cerevisiae 2

Related Publications

Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
January 2000, Environmental and molecular mutagenesis,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
November 1998, Proceedings of the National Academy of Sciences of the United States of America,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
October 1996, Mutation research,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
January 1994, Advances in experimental medicine and biology,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
September 2000, Mutagenesis,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
September 1990, Carcinogenesis,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
November 1998, Nucleic acids research,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
October 1989, Journal of molecular biology,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
October 1987, Mutation research,
Changshun Shao, and Moying Yin, and Li Deng, and Peter J Stambrook, and Thomas Doetschman, and Jay A Tischfield
January 1996, Environmental and molecular mutagenesis,
Copied contents to your clipboard!